SecBot SecBot
Institutional Cluster

IBRX

ImmunityBio, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed8mo ago
Institutional cluster: 3 buyers, 0 sellers (bullish)
Actionable Insight ▲ Bullish

The absence of institutional selling and presence of coordinated accumulation, especially UBS's near-tripling of shares, suggests growing confidence among large financial players. Traders should monitor for follow-on buying, upcoming clinical trial data, or analyst upgrades as potential catalysts. However, given that all buyers are passive mega-banks, this may reflect index rebalancing rather than active conviction.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$10.44
T+0 close · Feb 28, 2026 · via day close
Latest settled
−24.14%
T+60 · $7.92
Vs SPY
−33.46%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 2 $10.44entry
  2. T+1 · 9mo ago −4.21%α −3.30% · $10.00
  3. T+5 · 8mo ago −19.06%α −17.85% · $8.45
  4. T+20 · 8mo ago −36.21%α −28.27% · $6.66
  5. T+60 · 6mo ago −24.14%α −33.46% · $7.92

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three major passive institutional investors, Morgan Stanley, Wells Fargo, and UBS, increased their positions in ImmunityBio (IBRX) during Q4 2024, with UBS doubling its stake and the group collectively adding $4.4M in net new value. Despite a minor valuation dip at Wells Fargo, all moves reflect strong accumulation, concentrated among large financial institutions. This coordinated buying suggests growing institutional confidence in IBRX, potentially signaling sector interest in the company's immuno-oncology pipeline.

Key Financial Metrics

Direction
accumulating
Buy Value
$14.7M
Net Flow
$4.4M

Institutional Positions

Net institutional flow: $4.4M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Morgan StanleyADD+78.3%$10.3M$1.9M
Wells FargoADD+30.4%$355.0K-$40.5K
UBSDOUBLED+290.6%$4.1M$2.6M

Key Facts

  • Morgan Stanley increased holdings by 1.76M shares, adding $1.9M in value (total position now $10.3M)
  • UBS more than doubled its stake, adding 1.18M shares and increasing position value by $2.6M to $4.1M
  • Wells Fargo added 32.3K shares despite a slight drop in total position value from $395K to $355K, likely due to share price movement
  • No institutional selling observed in this cluster; 3 buyers, 0 sellers

Financial Impact

3 institutions accumulated $4.4M in net new positions during Q4 2024, increasing total holdings from $10.3M to $14.7M

market_capfloat_demandinstitutional_ownership

Risk Factors

  • All buyers are passive institutions (mega_passive), reducing the strength of the signal compared to active manager conviction
  • Wells Fargo's position value declined slightly despite share increase, indicating possible price pressure or lagging performance in the quarter

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-IBRX-2024-Q4

US Market Status

Market Closed · Opens Wed (9h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 28, 2026